A detailed history of Core Wealth Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Core Wealth Partners LLC holds 1,501 shares of AMGN stock, worth $432,092. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,501
Previous 1,052 42.68%
Holding current value
$432,092
Previous $329 Million 47.11%
% of portfolio
0.29%
Previous 0.22%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$309.38 - $337.38 $138,911 - $151,483
449 Added 42.68%
1,501 $484 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $262 - $319
-1 Reduced 0.09%
1,052 $329 Million
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $20,971 - $25,315
78 Added 8.0%
1,053 $299 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $6,392 - $7,211
25 Added 2.63%
975 $281 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $21,427 - $25,337
100 Added 11.76%
950 $211 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $191,921 - $233,920
850 New
850 $205 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Core Wealth Partners LLC Portfolio

Follow Core Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Wealth Partners LLC with notifications on news.